Net sales of $17.6 million, up 36% compared to $12.9 million in the first quarter of 2024. Durable Medical Equipment (DME) channel net sales of $13.8 million, up 14% compared to $12.1 million in the ...

Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

SAN RAFAEL, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced ...

SAN RAFAEL, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and ...

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2025 Earnings Call Transcript May 5, 2025 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.11 ...

Ekso Bionics Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Ekso Bionics’ ...

Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.11. Operator: Greetings, and welcome to the Ekso Bionics First Quarter 2025 Financial ...